Patents
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
10/2001
10/23/2001US6306840 Cell adhesion inhibitors
10/23/2001CA2107150C Chromenic derivatives having a triene lateral chain, process for the preparation thereof and pharmaceutical compositions containing them
10/23/2001CA2079189C (benzocycloalkyl) alkylamines, their preparation process and pharmaceutical compositions containing them
10/18/2001WO2001077106A1 A new paroxetine salt and a novel pharmaceutical product containing it
10/18/2001WO2001077105A1 Dual molecules containing a peroxide derivative, synthesis and therapeutic applications thereof
10/18/2001WO2001077104A1 Bicyclic heterocylces, medicaments containing said compounds, the use thereof and method for producing them
10/18/2001WO2001077101A1 Chemical compounds
10/18/2001WO2001077100A2 Benzoamide piperidine compounds as substance p antagonists
10/18/2001WO2001077097A2 Polycyclic aryl and heteroaryl substituted 4-pyrones useful for selective inhibition of the coagulation cascade
10/18/2001WO2001077095A2 Derivatives of alpha-mercaptoacetamide
10/18/2001WO2001077080A2 Pyrazole compounds having anti proliferative activity
10/18/2001WO2001077079A2 Polycyclic aryl and heteroaryl substituted 4-pyridones useful for selective inhibition of the coagulation cascade
10/18/2001WO2001076629A1 Soluble beta amyloid precursor protein secretion promoters
10/18/2001WO2001027087A3 Process for making boc-protected 3-aminohydantoins/thiohydantoins and 3-aminodihydrouracils/dihydrothiouracils
10/18/2001WO2000071518A3 Heterocyclic analgesic compounds and their use
10/18/2001US20010031865 Herbicides
10/18/2001US20010031779 Methods and materials for treating and preventing inflammation of mucosal tissue
10/18/2001US20010031777 Heterocyclic compounds and their therapeutic use
10/18/2001US20010031767 Used as antidepressants, to treat obsessive compulsive disorder, panic disorders, bulimia, anorexia, pain, obesity, senile demential, migraines, and social phobias
10/18/2001CA2405561A1 Polycyclic aryl and heteroaryl substituted 4-pyrones useful for selective inhibition of the coagulation cascade
10/18/2001CA2405306A1 Polycyclic aryl and heteroaryl substituted 4-pyridones useful for selective inhibition of the coagulation cascade
10/18/2001CA2405163A1 Soluble beta amyloid precursor protein secretion promoters
10/18/2001CA2405089A1 Benzoamide piperidine containing compounds and related compounds
10/18/2001CA2403012A1 Chemical compounds
10/17/2001EP1146045A1 Piperidine derivatives having effects on serotonin related systems
10/17/2001EP1144406A1 Antifungal azole derivatives having a fluorinated vinyl group and process for preparing same
10/17/2001EP1144405A1 Triazole compounds with dopamine-d3-receptor affinity
10/17/2001EP1144404A1 Piperidinylquinolines as protein tyrosine kinase inhibitors
10/17/2001EP1144403A1 Substitued pyrazoles as p38 kinase inhibitors
10/17/2001EP1144402A2 Substituted oximes and hydrazones as neurokinin antagonists
10/17/2001EP1144390A2 Kinase inhibitors
10/17/2001EP1144388A1 Acyl derivatives which treat vla-4 related disorders
10/17/2001EP1144384A1 Compounds which inhibit leukocyte adhesion mediated by vla-4
10/17/2001EP1144381A2 Substituted benzo[de]isoquinoline-1,3-diones
10/17/2001EP1143991A2 Inhibitors of h+k+ -atpase
10/17/2001EP1143970A1 Pyridine compounds, use and preparation thereof
10/17/2001EP1143959A2 Antifungal activity of dicationic molecules
10/17/2001EP0983265A4 Endothelin receptor antagonists
10/17/2001EP0865438B1 Oxymethoxy-3-aryl-pyrone derivatives
10/17/2001EP0754682B1 Aminostilbazole derivative and medicine
10/17/2001EP0709373B1 Pyrrolidine derivative
10/17/2001EP0618914B1 Oxiranyl methyl ethers exhibiting chirality, and their use as dopants in liquid-crystal mixtures
10/17/2001CN1318063A Process for obtaiing HMG-CoA reductase inhibitors of high purity
10/17/2001CN1318059A Isoquinolines as urokinase inhibitors
10/17/2001CN1318056A Pyridinum derivatives for management of aging-related and diabetic vascular complications, process for their prepn. and therepeutic uses thereof
10/17/2001CN1318055A Pyridine ketones useful as herbicides
10/17/2001CN1318053A Cyclopentanoue dihydropyridine compounds useful as potassium channel openers
10/17/2001CN1317965A Compounds having IgE affecting properties
10/17/2001CN1317964A Composition
10/17/2001CN1073108C Texane derivatives having pyridil substituted C13 side chain, their prepn. and their use as anti-tumor agents
10/17/2001CN1073107C Process for 2-substituted benzo [b] thiophene compounds and intermediates thereof
10/17/2001CN1073106C Taxoids compound, preparation thereof, and pharmaceutical compsns. contg. same
10/17/2001CN1073089C Benzodizaepine derivtive, its compsns. and use of preparing medicines
10/16/2001US6303814 N-[1,2,4]triazoloazinyl) benzenesulfonamide and pyridinesulfonamide compounds and their use as herbicides
10/16/2001US6303793 Intermediates for cyclin-dependent kinase inhibitors
10/16/2001US6303789 Benzamides with tetrahydrofuranyloxy substitutents as phosphodiesterase 4 inhibitors
10/16/2001US6303783 1- (3-Heterocyclylphenyl) isothiourea, -isourea, -guanidine and -amidine herbicidal agents
10/16/2001US6303633 Heteroaryl amines as novel acetylcholinesterase inhibitors
10/16/2001US6303628 Bicycliccarbonyl indole compounds as anti-inflammatory/analgesic agents
10/16/2001US6303627 For therapy of physiological and psychological disorders
10/16/2001US6303615 2,3 disubstituded-4(3H)-quinazolinones
10/16/2001US6303611 For therapy of hyperalgesis
10/16/2001US6303606 Use of selective antagonists of the α1B-adrenergic receptor for improvement of sexual dysfunction
10/16/2001US6303603 3-oxo-2(H)-1,2,4-triazine derivatives as ligands of 5 HT1A receptors
10/16/2001US6303602 Useful as analgesic, anesthetic, anti-inflammatory or neuroprotective agent, or for therapy of arthritis, stroke of functional bowel disease
10/16/2001US6303600 Substituted azabicyclic compounds
10/16/2001US6303593 For therapy human immunodeficiency virus infection, aquired immunodeficiency syndrome (aids), inflammatory and immunoregulatory disorder or disease, asthma, allergic rhinitis, dermatitis, conjunctivitis, atherosclerosis
10/16/2001US6303583 Continuous injection of 5-fluorouracil (5fu) for 3 to 48 hours once a week and oral administration of a mixture of 1-(tetrahydrofuryl)-5-fluorouracil and uracil (uft) one to four times a day for 3 to 7 days per week for cancer therapy
10/16/2001CA2035967C Oxetanones
10/16/2001CA2025301C New n-aryl and n-heteroarylamide and urea derivatives as inhibitors of acyl coenzyme a: cholesterol acyl transferase
10/11/2001WO2001074808A1 Novel 1,2,3,4-tetrahydrosioquinoline, their preparation method and their use as fungicides
10/11/2001WO2001074806A1 Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain
10/11/2001WO2001074805A1 Hydroxyphenyl-piperazinyl-methyl-benzamide derivatives for the treatment of pain
10/11/2001WO2001074804A1 Hydroxyphenyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatement of pain
10/11/2001WO2001074796A1 SUCCINOYLAMINO HETEROCYCLES AS INHIBITORS OF Aβ PROTEIN PRODUCTION
10/11/2001WO2001074791A1 Diazepane derivatives or salts thereof
10/11/2001WO2001074784A1 CYCLIC LACTAMS AS INHIBITORS OF A-β PROTEIN PRODUCTION
10/11/2001WO2001074775A1 Indolin-2-one derivatives, preparation and their use as ocytocin receptor ligands
10/11/2001WO2001074769A1 Pharmaceutically active pyrrolidine derivatives as bax inhibitors
10/11/2001WO2001074763A1 Aryl and heteroaryl sulfonates
10/11/2001WO2001074344A2 Small organic molecule regulators of cell proliferation
10/11/2001WO2001025210A3 Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and the use thereof as adenosine receptor ligands
10/11/2001WO2001021585A3 Bis(1-aziridino-1-hydroxyiminomethyl)-derivatives, method for the production thereof and use thereof as anti-tumoral agents
10/11/2001US20010029299 Psychological disorders; sleep disorders; anticonvulsants; cognition activators; drug abruse
10/11/2001DE10017539A1 New 6-acylamino-4-amino-quinazoline or quinoline derivatives, are tyrosine kinase-mediated signal transduction inhibitors useful e.g. for treating tumors or respiratory or gastrointestinal diseases
10/11/2001DE10015866A1 Aryl- und Heteroarylsulfonate Aryl and Heteroarylsulfonate
10/11/2001DE10015836A1 New epothilone derivatives used for treating e.g. malignant melanoma, breast carcinoma, psoriasis, multiple sclerosis and arthritis
10/11/2001CA2405126A1 Novel 1,2,3,4-tetrahydrosioquinoline, their preparation method and their use as fungicides
10/11/2001CA2404592A1 Indolin-2-one derivatives, preparation and their use as ocytocin receptor ligands
10/11/2001CA2404545A1 Aryl and heteroaryl sulfonates
10/11/2001CA2404413A1 Small organic molecule regulators of cell proliferation
10/11/2001CA2404386A1 Hydroxyphenyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain
10/11/2001CA2404314A1 Succinoylamino heterocycles as inhibitors of a.beta. protein production
10/11/2001CA2403600A1 Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain
10/11/2001CA2403550A1 Cyclic lactams as inhibitors of a-.beta. protein production
10/11/2001CA2402705A1 Hydroxyphenyl-piperazinyl-methyl-benzamide derivatives for the treatment of pain
10/11/2001CA2401137A1 Pharmaceutically active pyrrolidine derivatives as bax inhibitors
10/10/2001EP1142890A1 Aminopyrazole derivatives
10/10/2001EP1142887A1 5,6-dihydropyrone derivatives as protease inhibitors and antiviral agents
10/10/2001EP1142880A1 Benzimidazole derivatives